A Sweet Life: Critical Path’s New Initiative to Halt Type 1 Diabetes

With funding from Helmsley, the Critical Path Institute (C-Path) is launching a consortium focused on the prevention of type 1 diabetes (T1D).

A Sweet Life, the diabetes magazine, highlights how C-Path’s T1D Consortium will encourage cross-industry collaboration to design effective clinical trials to delay and ultimately prevent the progression of T1D.

Read the full piece at asweetlife.org.